HCK AS A THERAPEUTIC TARGET IN MYD88 MUTATED DISEASES
- 专利权人:
- Dana-Farber Cancer Institute; Inc.
- 发明人:
- Steven P. Treon,Guang Yang,Nathanael S. Gray,Sara Jean Buhrlage,Li Tan
- 申请号：
- US15581736
- 公开号：
- US20170333436A1
- 申请日:
- 2017.04.28
- 申请国别(地区):
- US
- 年份:
- 2017
- 代理人:
- 摘要：
- Methods of treatment of conditions or diseases associated with myeloid differentiation primary response (MYD88) protein using a selective HCK inhibitor are provided herein.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Hck כיעד רפואי במחלות קשורות למוטציה ב-myd88
- HCK as a therapeutic target in MYD88 mutated diseases
- 1H-PIRROLO [2,3-C] PIRIDIN-7 (6H) -ONE and Pyrazolo [3,4-C] Pyridine-7 (6H) -OH as BET Protein Inhibitors
- TRICYCLIC HETEROCYCLES FOR USE AS BET PROTEIN INHIBITORS
- TRICYCLIC HETEROCYCLES AS BET PROTEIN INHIBITORS
